- Home
- PRLD vs BGSF Comparison
PRLD vs BGSF Comparison
Compare PRLD & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | BGSF |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 49.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | BGSF |
|---|---|---|
| Price | $1.54 | $4.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 554.7K | 67.9K |
| Earning Date | 11-12-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 44.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,500,000.00 | ★ $263,687,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.00 | 71.60 |
| 52 Week Low | $0.61 | $2.91 |
| 52 Week High | $4.22 | $8.22 |
Technical Indicators
Market Signals| Indicator | PRLD | BGSF |
|---|---|---|
| Relative Strength Index (RSI) | 50.02 | 59.36 |
| Support Level | $1.30 | $4.29 |
| Resistance Level | $1.70 | $4.76 |
| Average True Range (ATR) | 0.17 | 0.22 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 56.32 | 69.57 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.